
|Articles|January 17, 2006
Urology Times BPA Statement, July 2005
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Experts urge FDA to revisit labeling for testosterone replacement therapy in men
2
FDA approves flibanserin for hypoactive sexual desire disorder in postmenopausal women
3
FDA approves first-line Zenflow system for the treatment of BPH
4
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
5

















